Quick Answer
Quoin Pharmaceuticals, Ltd. reported Earnings Per Share Diluted of $0.01 (loss) per share for the year ending 2021.
- Quoin Pharmaceuticals, Ltd. showed an increase of +98.6% in Earnings Per Share Diluted from 2020 to 2021.
- This data is from Quoin Pharmaceuticals, Ltd.'s annual report (Form 10-K), filed with the SEC on April 14, 2022.
- XBRL data for this metric is available from 2019 to 2021 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2019 to 2021), Quoin Pharmaceuticals, Ltd.'s Earnings Per Share Diluted has grown by 98.1%.
- Historical annual values: Fiscal year 2021: $0.01 (loss) per share | Fiscal year 2020: $0.70 (loss) per share | Fiscal year 2019: $0.52 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: